As the activation of microglia-expressed α7nAChR induces anti-inflammatory effects, this receptor has been proposed as a promising target for the prevention and treatment of cognitive impairment in patients with psychiatric disorders such as schizophrenia83,84. This evidence concerns the gene CHRNA7 and Cognitive impairment.